Frances Marie McLaren

Title: Frances Marie McLaren: Innovator in Pain Management

Introduction: Frances Marie McLaren, based in Wilmington, Delaware, is a prominent inventor recognized for her contributions to the field of pain management. With a total of three patents to her name, McLaren’s work focuses on the development of novel compounds aimed at alleviating pain.

Latest Patents: Among her latest inventions, McLaren has patented the compounds 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their applications for treating pain. The examiner's statement of allowance noted that McLaren's amendments to the claims effectively limited the compound structure, which previously faced rejections. Additionally, she has developed 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione, highlighting its therapeutic potential. This compound, along with its (−) enantiomer and pharmaceutically acceptable salts, demonstrates a promising method for pain treatment.

Career Highlights: Frances McLaren is currently an inventor at AstraZeneca AB, a leading company in the pharmaceutical industry known for its innovative research and development. Her career reflects a strong commitment to creating effective solutions for pain management, having accomplished significant advancements through her patented innovations.

Collaborations: Throughout her career, McLaren has collaborated with notable colleagues, including Dean Brown and Rebecca Urbanek. These collaborations have likely enriched her research endeavors, combining their expertise to push the boundaries of pain management solutions.

Conclusion: Frances Marie McLaren's impactful work in developing new compounds for pain treatment showcases her role as an influential inventor in the pharmaceutical realm. Through her patents and collaborations, she continues to contribute to advancements that may improve the quality of life for individuals suffering from pain.